InvestorsHub Logo

Oceanfreedom

09/21/16 6:16 PM

#3848 RE: ash111 #3842

Agree Ash. Talking the whole world here. Also, When looking at these numbers you have to put yourself into the buyout co. shoes (Teva, Pfizer, etc..) A large bio would already have a massive sales network established with Celebrex or generic version. The Right partner of kit-302 makes all the difference. The right partner could "Dominate the Market" with this so its more valuable to them.